Ocular Genomics
243 Charles Street Boston, MA 02114 Contact us
Diagnostic Testing
Support our research
Explore our labs
Ocular Genomics MENU
Ocular Genomics
  • News & Publications
    • RETINAL Transcriptome
  • Affiliates
  • Careers
  • Rates
  • Order Information
  • Contact Us
  • Pricing
  • Home
  • 2018
  • March

Featured Posts

  • Work by Caitlin Collin & Qin Liu highlighted at ARVO 2021 meeting
  • Ground-breaking study to restore vision uses CRISPR technology
  • Licensing Agreement with Biogen to Develop Treatment for Inherited Retinal Disorder

Recent Posts

  • Precision Medicine at Work
  • Work by Caitlin Collin & Qin Liu highlighted at ARVO 2021 meeting
  • Ground-breaking study to restore vision uses CRISPR technology
  • Ocular Genomics Institute Scientists publish large Gene-Wide Association Study of Glaucoma
  • AAVCOVID Vaccine developed by Luk Vandenberghe to start Clinical trials

Archives

  • June 2021
  • May 2021
  • March 2021
  • February 2021
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • June 2020
  • August 2019
  • May 2019
  • April 2019
  • May 2018
  • April 2018
  • March 2018
  • November 2017
  • September 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017

Categories

  • News
  • Publication
  • Uncategorized
Mass. Eye and Ear performs first FDA-approved gene therapy procedure for inherited disease
March 20, 2018

Massachusetts Eye and Ear made medical history on Tuesday by performing the first post-FDA approval gene therapy for patients with a form of inherited blindness. The occasion marks the beginning of a new era in medicine, as it is the first time any FDA-approved gene therapy has been given to a patient for any inherited disease. The treatment,... Read More


National School Walkout
March 20, 2018

Some members of the OGI  (including Dr. Pierce who served as the photographer) were able to join the National School Walkout this morning to remember victims of gun violence and support more stringent gun controls.


CRISPR trick in mice points the way to possible treatments for inherited diseases
March 8, 2018

  With the power of the genome-editing tool CRISPR on display, scientists around the world have been hard at work in recent years — developing CRISPR-based therapies that may one day edit disease-causing mutations in our DNA for the treatment of inherited disorders. But there are still great challenges with this powerful tool, and... Read More


Featured:

Contact Us

243 Charles Street
Boston, MA 02114

Labs

Sitemap

  • Affiliates
  • Careers
  • News & publications
  • Support Our Research
  • Privacy
website-boston WebsiteBoston